Fox Run Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,918	Closed	-$216K	–	1128
2025 Q3	$216K	Buy	+29,918	New	+$178K	0.03%	781
2024 Q4	–	Sell	-53,141	Closed	-$1.46M	–	1068
2024 Q3	$1.46M	Buy	+53,141	New	+$1.44M	0.32%	36
2024 Q2	–	Sell	-17,120	Closed	-$365K	–	967
2024 Q1	$365K	Buy	+17,120	New	+$368K	0.08%	470
2019 Q1	–	Sell	-25,703	Closed	-$747K	–	617
2018 Q4	$747K	Buy	25,703 +18,027	+235%	+$649K	0.4%	30
2018 Q3	$353K	Sell	7,676 -16,555	-68%	-$736K	0.15%	296
2018 Q2	$906K	Buy	+24,231	New	+$818K	0.29%	50
2017 Q2	–	Sell	-18,268	Closed	-$351K	–	756
2017 Q1	$351K	Buy	18,268 +1,168	+7%	+$20.7K	0.14%	312
2016 Q4	$285K	Buy	+17,100	New	+$309K	0.15%	316
2016 Q3	–	Sell	-12,800	Closed	-$392K	–	614
2016 Q2	$392K	Sell	12,800 -6,700	-34%	-$233K	0.19%	191
2016 Q1	$730K	Buy	+19,500	New	+$735K	0.49%	24